Use access key #2 to skip to page content.
$14.83 0.00 (0.00%)
10/13/2008 4:00 PM

Bentley Pharmaceuticals, Inc. (BNT)

CAPS Rating:
****

A pharmaceutical company focused on: development, licensing and sale of generic and branded pharmaceutical products and active pharmaceutical ingredients; and research, development and licensing/commercialization of drug delivery technologies.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BNT

Add Stock to Watchlist

What the Community Thinks

Total Members

71 Outperforms
9 Underperforms
 

All-Stars

16 Outperforms
3 Underperforms
 

Wall Street

0 Outperforms
1 Underperforms
 

Members bullish on BNT are also bullish on:

Members bearish on BNT are also bearish on:

Ticker Tags

Micro Cap (5043), Pharmaceuticals (148)
Suggest a tag

Bentley Pharmaceuticals, Inc. At A Glance

Current Price: $14.83
Last Trade Time: 10/13/2008 4:00 PM
Open: $0.00
Previous Close: $14.83
Daily Range: $14.81 - $14.83
52-Week Range: $9.05 - $16.39
Volume: 1,480,109
Market Cap: $337.04M
P/E Ratio: 247.17
Compare Our Special Broker Offers!

Stock Trends

BNT VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for BNT

More Headlines...

Top Bull Pitch

Recs

1

Bentley Pharmaceuticals, Inc. (BNT)

Avatar msketers (61.80) Submitted: 3/08/07 9:59 PM

With several newly approved drugs to market, the future earnings should increase. Add on top of that the long term chance that the intranasal insulin would be marketable. This stock should rocket in the long term. That is provided they can get past the bad mojo around the BOD.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 12 :   1 2 3 Next »

Recs

0

 (BNT)

Avatar outoffocus (< 20) Submitted: 10/24/08 9:11 AM : Underperform Start Price: $14.83 BNT Score: -17.29

PE> 200

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BNT)

Avatar harrytong (23.73) Submitted: 10/17/08 3:30 AM : Underperform Start Price: $14.83 BNT Score: -19.13

Expensive.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BNT)

Avatar Armydoc1 (< 20) Submitted: 5/31/08 10:26 AM : Outperform Start Price: $14.18 BNT Score: 50.35

New products

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BNT)

Avatar gallunltd (< 20) Submitted: 5/01/08 6:51 PM : Outperform Start Price: $14.12 BNT Score: 51.36

The spin off of the drug delivery system is positive. The buyout by TEVA appears to be positive but then what? Short term out perform.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BNT)

Avatar EMG114 (< 20) Submitted: 4/28/08 9:59 PM : Outperform Start Price: $14.31 BNT Score: 48.32

As this company was recently acquired by another firm, I expect this stock to go up after it releases some news...hold on to this one.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 12 :   1 2 3 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer 85.65 03/23/06 Underperform 3W $11.86+25.08%-41.63%-66.71

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links